The immune system is poised to attack and destroy insulin-producing islet cells. DRI's Dr. Norma Kenyon reports on how mesenchymal stem cells may be used to promote the survival and long-term function of insulin-producing cells. The DRI leads the world in cure-focused research, pioneering new cell-based therapies to restore natural insulin production in those with diabetes...

Progress with Mesenchymal Stem cells

LFLN REF 25/09/12 p.70